Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

BUY
$101.89 - $150.09 $1.34 Million - $1.98 Million
13,200 Added 17.19%
90,000 $10.5 Million
Q4 2021

Feb 11, 2022

SELL
$118.18 - $153.21 $2.74 Million - $3.55 Million
-23,200 Reduced 23.2%
76,800 $11.6 Million
Q3 2021

Nov 12, 2021

SELL
$93.51 - $129.4 $2.42 Million - $3.35 Million
-25,920 Reduced 20.58%
100,000 $11.9 Million
Q1 2021

Apr 30, 2021

SELL
$81.28 - $104.34 $203,200 - $260,850
-2,500 Reduced 1.95%
125,920 $11.1 Million
Q4 2020

Feb 02, 2021

BUY
$86.4 - $121.75 $2.68 Million - $3.77 Million
31,000 Added 31.82%
128,420 $12.3 Million
Q3 2020

Nov 10, 2020

BUY
$95.43 - $116.09 $9.3 Million - $11.3 Million
97,420 New
97,420 $11.1 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.38B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.